StocksDeepDive
Snapshot · Russell 3000 · generated 2026-10-17 22:04 UTC

AMPH — Amphastar Pharmaceuticals, Inc.

UNDERVALUED (MOS +61.5%) · Quality 62/100

Price
25.87
Intrinsic value
67.16
Margin of safety
+61.5%
Implied growth (reverse DCF)
-2.1%
model assumes +13.1%
Value Score
39.6
Quality
62
Psychology
-12.8
Discovery
10.3
price/volume attention only
Moat score
54.8
erosion: none

Value Score: top 26% of Russell 3000 · Quality: top 33%

Open the interactive Deep Dive for AMPH →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/AMPH - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is AMPH undervalued?

As of 2026-10-17, AMPH trades at 25.87 against a computed intrinsic value of 67.16 (+61.5% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Amphastar Pharmaceuticals, Inc.'s Value Score?

Amphastar Pharmaceuticals, Inc.'s Value Score is 39.6 as of 2026-10-17 - it combines value, quality, crowd psychology and market attention into one number.